Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BACH-F study of carvedilol versus metoprolol in chronic heart failure
NL-OMON21698Active, not recruiting
- Sponsor
- P.W. Kamphuisen, internist, Vasculair Geneeskundige.
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of carvedilol and metoprolol in chronic heart failure (CHF), sponsored by P.W. Kamphuisen, internist, Vasculair Geneeskundige. Primary endpoint: Sympathetic activity. Started Sep 2007; status: active, not recruiting.
02
Drugs
carvedilolmetoprolol
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NL-OMON21698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21698.